Form 8-K - Current report:
SEC Accession No. 0001193125-25-308794
Filing Date
2025-12-05
Accepted
2025-12-05 09:15:30
Documents
16
Period of Report
2025-12-05
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d20776d8k.htm   iXBRL 8-K 41046
2 EX-2.1 d20776dex21.htm EX-2.1 640091
3 EX-99.1 d20776dex991.htm EX-99.1 14314
8 GRAPHIC g20776g1204234658833.jpg GRAPHIC 6062
  Complete submission text file 0001193125-25-308794.txt   994019

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xoma-20251205.xsd EX-101.SCH 4580
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20251205_def.xml EX-101.DEF 14449
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20251205_lab.xml EX-101.LAB 24599
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20251205_pre.xml EX-101.PRE 15482
19 EXTRACTED XBRL INSTANCE DOCUMENT d20776d8k_htm.xml XML 7796
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 251551376
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)